Disclosures for "Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Participants"
-
Dr. Lefèvre has nothing to disclose.
-
Dr. Tian has received personal compensation for serving as an employee of Novartis. Dr. Tian has stock in Novartis. Dr. Tian has a non-compensated relationship as a Director of PKS with Novartis that is relevant to AAN interests or activities.
-
Dr. choudhury has nothing to disclose.
-
Dr. Willi has received personal compensation for serving as an employee of Novartis Pharma. Dr. Willi has received stock or an ownership interest from Novartis.
-
Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
-
Mrs. Liu has nothing to disclose.
-
Mr. BEECHAM has nothing to disclose.
-
Dr. Vormfelde has received personal compensation for serving as an employee of Novartis. Dr. Vormfelde has stock in Novartis.
-
Dr. Tillmann has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Tillmann has stock in Novartis Pharma AG. Dr. Tillmann has stock in Alcon . Dr. Tillmann has stock in Sandoz.